Covestor Ltd Purchases 171 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Covestor Ltd raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 12.8% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 1,511 shares of the company’s stock after acquiring an additional 171 shares during the period. Covestor Ltd’s holdings in Henry Schein were worth $114,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of HSIC. Arizona State Retirement System grew its position in Henry Schein by 0.4% in the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after purchasing an additional 149 shares during the period. Empirical Finance LLC grew its holdings in shares of Henry Schein by 3.5% during the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after buying an additional 160 shares during the last quarter. Keene & Associates Inc. increased its position in shares of Henry Schein by 4.0% during the first quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after acquiring an additional 175 shares in the last quarter. Wahed Invest LLC raised its holdings in shares of Henry Schein by 9.2% in the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock worth $168,000 after acquiring an additional 187 shares during the last quarter. Finally, Crossmark Global Holdings Inc. lifted its position in Henry Schein by 1.5% in the 4th quarter. Crossmark Global Holdings Inc. now owns 13,090 shares of the company’s stock valued at $991,000 after acquiring an additional 197 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

NASDAQ HSIC traded down $1.03 during trading hours on Tuesday, reaching $69.92. 561,702 shares of the company were exchanged, compared to its average volume of 1,097,223. The stock has a market capitalization of $8.95 billion, a P/E ratio of 23.61, a P/E/G ratio of 1.74 and a beta of 0.87. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The business’s 50 day simple moving average is $68.34 and its 200-day simple moving average is $71.94.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The company’s revenue was up 3.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.21 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

Analysts Set New Price Targets

HSIC has been the subject of a number of recent research reports. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday. Barrington Research reissued an “outperform” rating and issued a $92.00 price target on shares of Henry Schein in a research report on Friday, July 5th. Evercore ISI cut their price objective on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. Robert W. Baird upgraded shares of Henry Schein from a “neutral” rating to an “outperform” rating and increased their target price for the company from $81.00 to $92.00 in a report on Monday. Finally, UBS Group dropped their price target on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 8th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $81.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.